PLASMA FIBRIN DEGRADATION PRODUCTS EVOLUTION IN PATIENTS WITH DEEP-VEIN THROMBOSIS TREATED WITH A LOW-MOLECULAR WEIGHT HEPARIN FRACTION (CY222) AND STANDARD HEPARIN

被引：0
|
作者：
FAIVRE, R [1 ]
NEUHART, E [1 ]
SORIA, C [1 ]
SORIA, J [1 ]
KIEFFER, Y [1 ]
DUCELLIER, D [1 ]
BASSAND, JP [1 ]
CAEN, J [1 ]
MAURAT, JP [1 ]
机构：
[1] UNIV LARIBOISIERE, PARIS, FRANCE
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1989年 / 556卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：441 / 443
页数：3
相关论文
共 50 条
  • [31] PLACENTA CROSSING OF HEPARIN AND OF A LOW-MOLECULAR WEIGHT HEPARIN FRAGMENT CY-222 IN RABBIT
    DOUTREMEPUICH, C
    FANTAUZZI, B
    MASSE, A
    REFAUVELET, J
    BOUSQUET, F
    TOULEMONDE, F
    QUILICHINI, R
    [J]. PATHOLOGIE BIOLOGIE, 1985, 33 (06): : 677 - 679
  • [32] LOW-MOLECULAR-WEIGHT HEPARIN AND PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS
    KAKKAR, VV
    DJAZAERI, B
    FOK, J
    FLETCHER, M
    SCULLY, MF
    WESTWICK, J
    [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6313): : 375 - 380
  • [33] PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS (DVT) IN MALIGNANT PATIENTS BY FRAXIPARINE (A LOW-MOLECULAR WEIGHT HEPARIN) - A COOPERATIVE TRIAL
    DAHAN, M
    LEVASSEUR, P
    BOGATY, J
    BONEU, B
    SAMAMA, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 519 - 519
  • [34] Is standard heparin superior to low molecular weight heparin in malignancy related deep vein thrombosis?
    Tecimer, C
    Bhupalam, L
    Djulbegovic, B
    [J]. BLOOD, 1997, 90 (10) : 3265 - 3265
  • [35] INTRAVENOUS LOW-MOLECULAR-WEIGHT HEPARIN VS HEPARIN FOR THE INITIAL TREATMENT OF DEEP-VEIN THROMBOSIS
    MERLI, G
    COMP, P
    ELLIOTT, G
    ROSSI, M
    TROY, S
    HOLLOWAY, S
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1117 - 1117
  • [36] CHANGES IN PLASMA FIBRIN DEGRADATION PRODUCTS AS A MARKER OF THROMBUS EVOLUTION IN PATIENTS WITH DEEP-VEIN THROMBOSIS
    MIRSHAHI, M
    SORIA, C
    SORIA, J
    MIRSHAHI, M
    FAIVRE, R
    KIEFFER, Y
    BASSAND, JP
    TOULEMONDE, F
    CAEN, J
    [J]. THROMBOSIS RESEARCH, 1988, 51 (03) : 295 - 302
  • [37] EFFICACY AND SAFETY OF A LOW-MOLECULAR-WEIGHT HEPARIN ( LMW-HEPARIN SANDOZ ) IN PATIENTS WITH DEEP-VEIN THROMBOSIS
    VOGEL, G
    MACHULIK, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 120 - 120
  • [38] 95 CASES OF DEEP VENOUS THROMBOSIS OF THE LOWER-EXTREMITIES TREATED WITH A HEPARIN OF EXTREMELY LOW-MOLECULAR-WEIGHT, CY222 - CLINICAL AND PHLEBOGRAPHIC RESULTS
    JANVIER, G
    WINNOCK, S
    DUGRAIS, G
    VERGNES, D
    BOISSEAU, M
    BROUSSIN, J
    SERISK, JM
    CALEN, S
    BOISSIERAS, P
    TOULEMONDE, F
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1987, 29 (02): : 143 - 143
  • [39] STRATEGY FOR THE DEVELOPMENT OF THE LOW-MOLECULAR WEIGHT HEPARIN FRACTION CY-216 IN THE PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSES IN GENERAL-SURGERY
    TOULEMONDE, F
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (04): : 395 - 400
  • [40] LOW-MOLECULAR WEIGHT HEPARIN (ALFA LHWH) COMPARED WITH UNFRACTIONATED HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS AFTER HIP-FRACTURES
    PINI, M
    TAGLIAFERRI, A
    MANOTTI, C
    LASAGNI, F
    RINALDI, E
    DETTORI, AG
    [J]. INTERNATIONAL ANGIOLOGY, 1989, 8 (03) : 134 - 139
12345